Springer Nature OA
open access
Assessing Safety in Vaccine Clinical Trials
This chapter discusses the safety and pharmacovigilance considerations in a vaccine clinical development program. Participant safety is of great importance to all parties involved in clinical studies: the participant themselves, the investigators who recruit and enroll participants and answer to ins
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu Vaccine in Children Previously Vaccinated in Trial V118_05 (NCT01964989)#208276
- Our Epistemic Duties in Scenarios of Vaccine Mistrust#83761
- Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults#1009799
- Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine#916570
- A Phase 1 Randomized, Observer-blind, Placebo-controlled, Dose-escalation Clinical Trial to Evaluate the Safety and Immunogenicity of rVSV∆G-MARV-GP Vaccine in Adults in Good General Health#195381
Record · ID 1428423
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive